Literature DB >> 11156081

Where is the boundary between N1 and N2 stations in lung cancer?

H Asamura1, K Suzuki, H Kondo, R Tsuchiya.   

Abstract

BACKGROUND: The anatomical definition of N1 stations, its boundary to N2 stations, and its prognostic implication are yet to be defined in lung cancer. Metastasis in lymph nodes close to the pleural reflection has been classified differently as N1 or N2 according to the lymph node maps promulgated so far.
METHODS: The pattern of lymphatic involvement and prognosis were retrospectively analyzed in 180 N1 patients who underwent at least lobectomy and complete hilar/mediastinal lymphadenectomy from 1987 through 1997. For comparison, the prognoses of 166 N2 patients were also analyzed.
RESULTS: The overall 5-year survival of N1 and N2 patients was 67% and 37%, respectively, and the difference was statistically significant (p = 0.0000, log-rank test). The prognosis was compared between N1 without No. 10 involvement (N1-, n = 145), N1 with No. 10 involvement (N1+, n = 35), and N2 (n = 166). Their 5-year survival was 70%, 54%, and 37%, respectively. A significant difference was observed only between N1+ and N2 (p = 0.04), and not observed between N1- and N1+. However, survival curves of single-node N2 (n = 66) and N1+ were superimposed.
CONCLUSIONS: In terms of prognosis, a pleural reflection does not seem an appropriate anatomical boundary between N1 and N2 stations in lung cancer.

Entities:  

Mesh:

Year:  2000        PMID: 11156081     DOI: 10.1016/s0003-4975(00)01817-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.

Authors:  John C Haney; Jennifer M Hanna; Mark F Berry; David H Harpole; Thomas A D'Amico; Betty C Tong; Mark W Onaitis
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-02       Impact factor: 5.209

Review 2.  Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions.

Authors:  Carmen Vallejo Ocańa; Pilar Garrido López; Ignacio Muguruza Trueba
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

3.  Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.

Authors:  Hajime Maeda; Shimao Fukai; Akihide Matsumura; Osamu Kawashima; Takehiro Watanabe; Takeshi Yamanda; Kan Okabayashi; Yuka Fujita; Atsuhisa Tamura; Masaaki Kawahara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

Review 4.  Role and cost effectiveness of PET/CT in management of patients with cancer.

Authors:  Muhammad Wasif Saif; Ifigenia Tzannou; Nektaria Makrilia; Kostas Syrigos
Journal:  Yale J Biol Med       Date:  2010-06

Review 5.  Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment.

Authors:  Debora Brascia; Giulia De Iaco; Marcella Schiavone; Teodora Panza; Francesca Signore; Alessandro Geronimo; Doroty Sampietro; Michele Montrone; Domenico Galetta; Giuseppe Marulli
Journal:  Cancers (Basel)       Date:  2020-07-25       Impact factor: 6.639

6.  Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes.

Authors:  Hongfeng Liu; Tao Yan; Tiehong Zhang; Xiaowei Chen; Yadong Wang; Jiajun Du
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.

Authors:  Wei Chen; Chenlei Zhang; Gebang Wang; Zhanwu Yu; Hongxu Liu
Journal:  Thorac Cancer       Date:  2019-06-17       Impact factor: 3.500

8.  Adjuvant chemotherapy may improve outcome of patients with non-small-cell lung cancer with metastasis of intrapulmonary lymph nodes after systematic dissection of N1 nodes.

Authors:  Xing Wang; Shi Yan; Yaqi Wang; Xiang Li; Chao Lyu; Yuzhao Wang; Jia Wang; Shaolei Li; Lijian Zhang; Yue Yang; Nan Wu
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.